Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial
Oxana Palesh(Virginia Commonwealth University), Karen M. Mustian(University of Rochester Medical Center), Shelli R. Kesler(The University of Texas at Austin), Caroline Scheiber(Stanford University), Charles E. Heckler(University of Rochester Medicine), Nick G. Chrysson(National Cancer Centre Japan), Joseph J. Guido(Seagen (Canada)), Michelle C. Janelsins(University of Rochester), J. Martin Miller(Metro-Minnesota Community Oncology Research Consortium), Mallory G. Cases(Stanford University)
Cited by 59
Related Papers
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
|Journal of Clinical Oncology|1999|960
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Applied Discriminant Analysis
|Technometrics|1995|409